Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings from the Longitudinal Youth at Risk Study

Schizophrenia Bulletin

Volumn 41, Issue 6, 2015, Pages 1285-1293

  Klauser, Paul ^a,b   Zhou, Juan ^c   Lim, Joseph K W ^c   Poh, Joann S ^c   Zheng, Hui ^c   Tng, Han Ying ^c   Krishnan, Ranga ^c   Lee, Jimmy ^c,d   Keefe, Richard S E ^e   Adcock, R Alison ^e,f   Wood, Stephen J ^a,g   Fornito, Alex ^a,b   Chee, Michael W L ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d INSTITUTE OF MENTAL HEALTH   (Singapore)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DUKE UNIVERSITY   (United States)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Early psychosis; Magnetic resonance imaging; Schizophrenia; Surface based morphometry; Voxel based morphometry

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BRAIN REGION; BRAIN SIZE; COMORBIDITY; CONTROLLED STUDY; CORTICAL THICKNESS (BRAIN); DEPRESSION; FEMALE; FOLLOW UP; GRAY MATTER; HIPPOCAMPUS; HUMAN; KERNEL METHOD; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SURFACE BASED MORPHOMETRY; VOXEL BASED MORPHOMETRY; WHITE MATTER; BRAIN CORTEX; PATHOLOGY; RISK; SINGAPORE; YOUNG ADULT;

ADOLESCENT; ADULT; CEREBRAL CORTEX; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PSYCHOTIC DISORDERS; RISK; SINGAPORE; WHITE MATTER; YOUNG ADULT;

EID: 84946127198     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv012     Document Type: Article

References (80)

1. Fusar-Poli P, Bonoldi I, Yung AR, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69:220-229.
2. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29:703-715.
3. Yung AR, Yuen HP, McGorry PD, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005;39:964-971.
4. Borgwardt SJ, Riecher-Rössler A, Dazzan P, et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry. 2007;61:1148-1156.
5. Meisenzahl EM, Koutsouleris N, Gaser C, et al. Structural brain alterations in subjects at high-risk of psychosis: a voxelbased morphometric study. Schizophr Res. 2008;102:150-162.
6. Koutsouleris N, Schmitt GJ, Gaser C, et al. Neuroanatomical correlates of different vulnerability states for psychosis and their clinical outcomes. Br J Psychiatry. 2009;195:218-226.
7. Fusar-Poli P, Broome MR, Woolley JB, et al. Altered brain function directly related to structural abnormalities in people at ultra high risk of psychosis: longitudinal VBM-fMRI study. J Psychiatr Res. 2011;45:190-198.
8. Fusar-Poli P, Crossley N, Woolley J, et al. Gray matter alterations related to P300 abnormalities in subjects at high risk for psychosis: longitudinal MRI-EEG study. Neuroimage. 2011;55:320-328.
9. Smieskova R, Allen P, Simon A, et al. Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study. Hum Brain Mapp. 2012;33:2281-2294.
10. Stone JM, Day F, Tsagaraki H, et al.; OASIS. Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol Psychiatry. 2009;66:533-539.
11. Wood SJ, Pantelis C, Velakoulis D, Yücel M, Fornito A, McGorry PD. Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull. 2008;34:322-329.
12. Pantelis C, Yücel M, Bora E, et al. Neurobiological markers of illness onset in psychosis and schizophrenia: The search for a moving target. Neuropsychol Rev. 2009;19:385-398.
13. Ellison-Wright I, Glahn DC, Laird AR, Thelen SM, Bullmore E. The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis. Am J Psychiatry. 2008;165:1015-1023.
14. Fornito A, Yücel M, Patti J, Wood SJ, Pantelis C. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res. 2009;108:104-113.
15. Fusar-Poli P, Borgwardt S, Crescini A, et al. Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev. 2011;35:1175-1185.
16. Mechelli A, Riecher-Rössler A, Meisenzahl EM, et al. Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry. 2011;68:489-495.
17. Jung WH, Kim JS, Jang JH, et al. Cortical thickness reduction in individuals at ultra-high-risk for psychosis. Schizophr Bull. 2011;37:839-849.
18. Cannon TD, Chung Y, He G, et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biol Psychiatry. 2015;77:147-157.
19. Tognin S, Riecher-Rössler A, Meisenzahl EM, et al. Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis. Psychol Med. 2014;44:489-498.
20. Ziermans TB, Durston S, Sprong M, et al. No evidence for structural brain changes in young adolescents at ultra high risk for psychosis. Schizophr Res. 2009;112:1-6.
21. Koutsouleris N, Gaser C, Patschurek-Kliche K, et al. Multivariate patterns of brain-cognition associations relating to vulnerability and clinical outcome in the at-risk mental states for psychosis. Hum Brain Mapp. 2012;33:2104-2124.
22. Ziermans TB, Schothorst PF, Schnack HG, et al. Progressive structural brain changes during development of psychosis. Schizophr Bull. 2012;38:519-530.
23. Dazzan P, Soulsby B, Mechelli A, et al. Volumetric abnormalities predating the onset of schizophrenia and affective psychoses: an MRI study in subjects at ultrahigh risk of psychosis. Schizophr Bull. 2012;38:1083-1091.
24. Pantelis C, Velakoulis D, McGorry PD, et al. Neuroanatomical abnormalities before and after onset of psychosis: a crosssectional and longitudinal MRI comparison. Lancet. 2003;361:281-288.
25. Jung WH, Jang JH, Shin NY, et al. Regional brain atrophy and functional disconnection in Broca's area in individuals at ultra-high risk for psychosis and schizophrenia. PLoS One. 2012;7:e51975.
26. Nakamura K, Takahashi T, Nemoto K, et al. Gray matter changes in subjects at high risk for developing psychosis and first-episode schizophrenia: a voxel-based structural MRI study. Front Psychiatry. 2013;4:16.
27. Dargan PI, Wood DM. Recreational drug use in the Asia Pacific region: improvement in our understanding of the problem through the UNODC programmes. J Med Toxicol. 2012;8:295-299.
28. Koskinen J, Löhönen J, Koponen H, Isohanni M, Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull. 2010;36:1115-1130.
29. Malchow B, Hasan A, Fusar-Poli P, Schmitt A, Falkai P, Wobrock T. Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci. 2013;263:3-13.
30. Rapp C, Bugra H, Riecher-Rössler A, Tamagni C, Borgwardt S. Effects of cannabis use on human brain structure in psychosis: a systematic review combining in vivo structural neuroimaging and post mortem studies. Curr Pharm Des. 2012;18:5070-5080.
31. Habets P, Marcelis M, Gronenschild E, Drukker M, van Os J. Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol Psychiatry. 2011;69:487-494.
32. Welch KA, McIntosh AM, Job DE, et al. The impact of substance use on brain structure in people at high risk of developing schizophrenia. Schizophr Bull. 2011;37:1066-1076.
33. Welch KA, Stanfield AC, McIntosh AM, et al. Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia. Br J Psychiatry. 2011;199:386-390.
34. Rapp C, Walter A, Studerus E et al. Cannabis use and brain structural alterations of the cingulate cortex in early psychosis. Psychiatry Res 2013;214:102-108.
35. Lee J, Rekhi G, Mitter N, et al. The Longitudinal Youth at Risk Study (LYRIKS)-an Asian UHR perspective. Schizophr Res. 2013;151:279-283.
36. Mitter N, Nah GQ, Bong YL, Lee J, Chong SA. Longitudinal Youth-At-Risk Study (LYRIKS): outreach strategies based on a community-engaged framework. Early Interv Psychiatry. 2014;8:298-303.
37. Jack CR, Bernstein MA, Fox NC, et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008;27:685-691.
38. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95-113.
39. Friston KJ, Worsley KJ, Frackowiak RSJ, Mazziotta JC, Evans AC. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp. 1993;1:210-220.
40. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002;15:1-25.
41. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage. 1999;9:179-194.
42. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage. 1999;9:195-207.
43. Buckner RL, Head D, Parker J, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage. 2004;23:724-738.
44. Fusar-Poli P, Radua J, McGuire P, Borgwardt S. Neuroanatomical maps of psychosis onset: voxel-wise metaanalysis of antipsychotic-naive VBM studies. Schizophr Bull. 2012;38:1297-1307.
45. Lee JK, Lee JM, Kim JS, Kim IY, Evans AC, Kim SI. A novel quantitative cross-validation of different cortical surface reconstruction algorithms using MRI phantom. Neuroimage. 2006;31:572-584.
46. Hutton C, De Vita E, Ashburner J, Deichmann R, Turner R. Voxel-based cortical thickness measurements in MRI. Neuroimage. 2008;40:1701-1710.
47. Hurlemann R, Jessen F, Wagner M, et al. Interrelated neuropsychological and anatomical evidence of hippocampal pathology in the at-risk mental state. Psychol Med. 2008;38:843-851.
48. Phillips LJ, Velakoulis D, Pantelis C, et al. Non-reduction in hippocampal volume is associated with higher risk of psychosis. Schizophr Res. 2002;58:145-158.
49. Witthaus H, Mendes U, Brüne M, et al. Hippocampal subdivision and amygdalar volumes in patients in an at-risk mental state for schizophrenia. J Psychiatry Neurosci. 2010;35:33-40.
50. Wood SJ, Yücel M, Velakoulis D, et al. Hippocampal and anterior cingulate morphology in subjects at ultra-high-risk for psychosis: the role of family history of psychotic illness. Schizophr Res. 2005;75:295-301.
51. Wood SJ, Kennedy D, Phillips LJ, et al. Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study. Neuroimage. 2010;52:62-68.
52. Buehlmann E, Berger GE, Aston J, et al. Hippocampus abnormalities in at risk mental states for psychosis? A crosssectional high resolution region of interest magnetic resonance imaging study. J Psychiatr Res. 2010;44:447-453.
53. Velakoulis D, Wood SJ, Wong MT, et al. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry. 2006;63:139-149.
54. Morey RA, Petty CM, Xu Y, et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. Neuroimage. 2009;45:855-866.
55. Fusar-Poli P, Nelson B, Valmaggia L, Yung AR, McGuire PK. Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: impact on psychopathology and transition to psychosis. Schizophr Bull. 2014;40:120-131.
56. Bresnahan M, Begg MD, Brown A, et al. Race and risk of schizophrenia in a US birth cohort: another example of health disparity? Int J Epidemiol. 2007;36:751-758.
57. Fearon P, Kirkbride JB, Morgan C, et al. Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med. 2006;36:1541-1550.
58. Hjern A, Wicks S, Dalman C. Social adversity contributes to high morbidity in psychoses in immigrants-a national cohort study in two generations of Swedish residents. Psychol Med. 2004;34:1025-1033.
59. Cohen CI, Marino L. Racial and ethnic differences in the prevalence of psychotic symptoms in the general population. Psychiatr Serv. 2013;64:1103-1109.
60. Morgan KD, Dazzan P, Morgan C, et al. Differing patterns of brain structural abnormalities between black and white patients with their first episode of psychosis. Psychol Med. 2010;40:1137-1147.
61. Ajnakina O, Borges S, Di Forti M, et al. Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis. Front Psychiatry. 2014;5:84.
62. United Nations Office on Drugs and Crime (2008). World Drug Report 2008. New York, NY: United Nations Publications.
63. Smieskova R, Fusar-Poli P, Aston J, et al. Insular volume abnormalities associated with different transition probabilities to psychosis. Psychol Med. 2012;42:1613-1625.
64. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57:1117-1127.
65. Di Forti M, Iyegbe C, Sallis H, et al. Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry. 2012;72:811-816.
66. Rais M, van Haren NE, Cahn W, et al. Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. Eur Neuropsychopharmacol. 2010;20:855-865.
67. Szeszko PR, Robinson DG, Sevy S, et al. Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br J Psychiatry. 2007;190:230-236.
68. Rocchetti M, Crescini A, Borgwardt S, et al. Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users. Psychiatry Clin Neurosci. 2013;67:483-492.
69. Ho BC, Andreasen NC, Ziebell S, Pierson R, Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry. 2011;68:128-137.
70. Girgis RR, Diwadkar VA, Nutche JJ, Sweeney JA, Keshavan MS, Hardan AY. Risperidone in first-episode psychosis: a longitudinal, exploratory voxel-based morphometric study. Schizophr Res. 2006;82:89-94.
71. Klauser P, Fornito A, Lorenzetti V, et al. Cortico-limbic network abnormalities in individuals with current and past major depressive disorder. J Affect Disord. 2015;173:45-52.
72. Modinos G, Allen P, Frascarelli M et al. Are we really mapping psychosis risk? Neuroanatomical signature of affective disorders in subjects at ultra high risk. Psychol Med 2014; 44:3491-3501.
73. Fusar-Poli P, Valmaggia L, McGuire P. Can antidepressants prevent psychosis? Lancet. 2007;370:1746-1748.
74. Cornblatt BA, Lencz T, Smith CW, et al. Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. J Clin Psychiatry. 2007;68:546-557.
75. Ioannidis JP. Excess significance bias in the literature on brain volume abnormalities. Arch Gen Psychiatry. 2011;68:773-780.
76. Fusar-Poli P, Radua J, Frascarelli M, et al. Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Hum Brain Mapp. 2014;35:3052-3065.
77. Borgwardt S, Radua J, Mechelli A, Fusar-Poli P. Why are psychiatric imaging methods clinically unreliable? Conclusions and practical guidelines for authors, editors and reviewers. Behav Brain Funct. 2012;8:46.
78. Yaakub SN, Dorairaj K, Poh JS, et al. Preserved working memory and altered brain activation in persons at risk for psychosis. Am J Psychiatry. 2013;170:1297-1307.
79. Dandash O, Fornito A, Lee J, et al. Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis. Schizophr Bull. 2014;40:904-913.
80. Jung WH, Borgwardt S, Fusar-Poli P, Kwon JS. Gray matter volumetric abnormalities associated with the onset of psychosis. Front Psychiatry. 2012;3:101.